Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Basic) (2016 - 2025)

Veracyte (VCYT) has disclosed EPS (Basic) for 14 consecutive years, with $0.52 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 642.86% to $0.52 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.84 through Dec 2025, up 162.5% year-over-year, with the annual reading at $0.84 for FY2025, 162.5% up from the prior year.
  • EPS (Basic) hit $0.52 in Q4 2025 for Veracyte, up from $0.24 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.52 in Q4 2025 to a low of -$0.66 in Q1 2021.
  • Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.12 in 2023.
  • Biggest five-year swings in EPS (Basic): tumbled 660.0% in 2023 and later soared 642.86% in 2025.
  • Year by year, EPS (Basic) stood at -$0.14 in 2021, then skyrocketed by 64.29% to -$0.05 in 2022, then crashed by 660.0% to -$0.38 in 2023, then soared by 118.42% to $0.07 in 2024, then skyrocketed by 642.86% to $0.52 in 2025.
  • Business Quant data shows EPS (Basic) for VCYT at $0.52 in Q4 2025, $0.24 in Q3 2025, and -$0.01 in Q2 2025.